Email alerts
Advanced Search
  • Jun 18, 2011
    VALOR II Study Highlights Strengths of Valiant(R) Thoracic Stent Graft from Medtronic
    Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study

    MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...

  • Jun 13, 2011
    Company Profile for Medtronic, Inc.

    Company Profile for Medtronic, Inc. Jun 13, 2011 (BUSINESS WIRE) -- Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with...

  • Jun 3, 2011
    Medtronic CFO Gary Ellis to Speak at Goldman Sachs Healthcare Conference

    MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...

  • May 24, 2011
    Medtronic Reports Fourth Quarter Earnings
    Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%

    MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...

  • May 24, 2011
    Medtronic Provides Initial Revenue Outlook and EPS Guidance for Fiscal Year 2012

    MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...

Show 5102550100 per page